| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |